Heart. Published Online First: 10 October 2005. doi:10.1136/hrt.2003.018325
Editorials |
Natriuretic peptides as a prognostic marker and therapeutic target in heart failure
1 University of Dundee, United Kingdom
* To whom correspondence should be addressed. E-mail: gary.gawright{at}gmail.com.
Accepted 25 September 2005
Abstract
Despite advances in therapy, patients with chronic heart failure still have high rates of mortality and hospital readmission. There is a real need for a relatively simple prognostic indicator in heart failure patients so that therapies can be better targeted. Natriuretic peptides have been shown to be powerful prognostic markers not only in the setting of heart failure but also now in acute coronary syndrome patients. Here we review the evidence that natriuretic peptides predict prognosis and evaluate how measuring these peptides might fit into everyday clinical practice.
Keywords: BNP, heart failure, natriuretic peptides, prognosis, therapy
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text (Rapid PDF)
-
All Versions of this Article:
hrt.2003.018325v1
92/2/149 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
